Order Article Reprints

Bavaro DF, Diella L, Belati A, Metrangolo G, De Santis L, Spada V, Camporeale M, Dargenio A, Brindicci G, Balena F, et al. Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study. Viruses. 2023; 15(5):1199. https://doi.org/10.3390/v15051199

Bavaro, Davide Fiore, Lucia Diella, Alessandra Belati, Giuliana Metrangolo, Laura De Santis, Vito Spada, Michele Camporeale, Angelo Dargenio, Gaetano Brindicci, Flavia Balena, and et al. 2023. "Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study" Viruses 15, no. 5: 1199. https://doi.org/10.3390/v15051199

Bavaro, D. F., Diella, L., Belati, A., Metrangolo, G., De Santis, L., Spada, V., Camporeale, M., Dargenio, A., Brindicci, G., Balena, F., Fiordelisi, D., Signorile, F., Loseto, G., Pasciolla, C., Minoia, C., Attolico, I., Perrone, T., Simone, S., Rendina, M., ... Saracino, A. (2023). Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study. Viruses, 15(5), 1199. https://doi.org/10.3390/v15051199